Atlas Trials

Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancer

Clinical trial NCT01180166 · UNKNOWN

Trial details

NCT number
NCT01180166
Sponsor
Chinese Academy of Medical Sciences
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric CancerConcurrent Chemoradiotherapy
Start date
2010-05-01
Primary completion
2013-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.